Cargando…

Efficacy and safety of intranasal haloperidol in an acute Psychiatry Unit: a pilot study on schizophrenic patients with mild-modedate agitation

To study the efficacy and safety of intranasal administration of 5 mg haloperidol on mild-moderate agitated patients with schizophrenia or schizoaffective disorder in an acute psychiatry unit setting

Detalles Bibliográficos
Autores principales:	Rosó, Duñó Ambròs, Joan Carles, Oliva Morera, María Luisa, Iglesias-Lepine, Diego, Palao Vidal, José Antonio Monreal Ortiz, Monreal Ortiz, Javier, Labad Arias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Actas Espanolas Psiquiatria 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335081/ https://www.ncbi.nlm.nih.gov/pubmed/34533203

Ejemplares similares

Religiosity and Psychotic Ideation in Stable Schizophrenia: A Role for Empathic Perspective-Taking
por: Duñó, Rosó, et al.
Publicado: (2020)

T225. OPERATIONAL DEFINITIONS FOR ANTIPSYCHOTIC RESPONSE IN DELUSIONAL DISORDER: A SYSTEMATIC AND CRITICAL REVIEW
por: González-Rodríguez, Alexandre, et al.
Publicado: (2018)

Haloperidol-Midazolam vs. Haloperidol-Ketamine in Controlling the Agitation of Delirious Patients; a Randomized Clinical Trial
por: Aghili, Mehrad, et al.
Publicado: (2023)

F229. THE BIOLOGICAL UNDERPINNINGS OF TREATMENT RESPONSE IN DELUSIONAL DISORDER: A SYSTEMATIC REVIEW OF QUALITATIVE EVIDENCE-TO-DATE
por: González-Rodríguez, Alexandre, et al.
Publicado: (2018)

Intranasal midazolam for rapid sedation of an agitated patient
por: Shrestha, Gentle Sunder, et al.
Publicado: (2015)

Sodium Valproate versus Continuous Infusion of Haloperidol in Management of Agitated Critically Ill Patients
por: Khalil, Ramadan, et al.
Publicado: (2019)

Schizophrenic Patients between General and Forensic Psychiatry
por: de Tribolet-Hardy, Fanny, et al.
Publicado: (2016)

Data of a meta-analysis on pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia
por: Labad, Javier, et al.
Publicado: (2020)

Effect of group psychotherapy on the annual incidence of self-harm and suicide attempts in borderline personality disorder: A pilot study
por: Figuereo, I., et al.
Publicado: (2021)

Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial
por: Reade, Michael C, et al.
Publicado: (2009)

Assessment and Management of Agitation in Consultation-Liaison Psychiatry
por: Raveesh, Bevinahalli Nanjegowda, et al.
Publicado: (2022)

Ethno-psychopharmacological aspects of treatment response in patients with delusional syndrome: A systematic review
por: Guàrdia, A., et al.
Publicado: (2021)

Are anxiety disorders a prelude to delusional disorder? A systematic review
por: Pedrero, A. Alvarez, et al.
Publicado: (2021)

Does ketamine provide a shorter time to sedation when compared to haloperidol and midazolam in the agitated ED patient?
por: Kent, Jessica, et al.
Publicado: (2021)

Monitoring of antipsychotic plasma levels in the assessment of poor response and nonadherence to antipsychotics in delusional disorder
por: González-Rodríguez, A., et al.
Publicado: (2021)

Pharmacokinetic interactions of psychotropic medications in patients with schizophrenia suffering from atypical mycobacterial infections
por: Sabaté, M. Betriu, et al.
Publicado: (2021)

Intranasal esketamine and the dawn of precision psychiatry
por: Watts, Devon, et al.
Publicado: (2021)

Ziprasidone, haloperidol and clonazepam intramuscular administration in the treatment of agitation symptoms in Chinese patients with schizophrenia: A network meta-analysis
por: Su, Liang, et al.
Publicado: (2018)

Intramuscular midazolam, olanzapine, or haloperidol for the management of acute agitation: A multi-centre, double-blind, randomised clinical trial
por: Chan, Esther W., et al.
Publicado: (2021)

Comparison of the Effects of Haloperidol and Dexmedetomidine on Delirium and Agitation in Patients with a Traumatic Brain Injury Admitted to the Intensive Care Unit
por: Soltani, Farhad, et al.
Publicado: (2021)

Study protocol for a randomised controlled trial of haloperidol plus promethazine plus chlorpromazine versus haloperidol plus promethazine for rapid tranquilisation for agitated psychiatric patients in the emergency setting (TREC-Lebanon)
por: Dib, Joseph E., et al.
Publicado: (2019)

Women with Schizophrenia over the Life Span: Health Promotion, Treatment and Outcomes
por: González-Rodríguez, Alexandre, et al.
Publicado: (2020)

Therapeutic implications of structural and functional neuroimaging findings in delusional disorder: A case report and review of literature
por: Fucho, G.F., et al.
Publicado: (2021)

The impact of sexual hormones on depressive symptoms and alcohol use in a woman with delusional disorder at the perimenopausal stage: case report and review of recent works
por: Fucho, G.F., et al.
Publicado: (2022)

Critical Issues in the Management of Agitation, Aggression, and End-of-Life in Delusional Disorder: A Mini-Review
por: González-Rodríguez, Alexandre, et al.
Publicado: (2023)

A retrospective cohort study of the prevalence of anxiety and agitation in schizophrenic smokers and the unmet needs of smoking cessation programs
por: Hassanzadah, Mehgan, et al.
Publicado: (2019)

Successful treatment of primary delusional parasitosis with paroxetine: A case report and narrative review
por: Delgado, L., et al.
Publicado: (2021)

Follow-up of patients with delusional disorder in a specialized outpatient clinic over a 2-year period
por: González-Rodríguez, A., et al.
Publicado: (2021)

Second-Generation Parenteral Antipsychotic (Olanzapine) as a First-Line Treatment for Acute Undifferentiated Agitation in the Emergency Department in Comparison With Haloperidol
por: Singh, Adheera P, et al.
Publicado: (2023)

Comorbidity and therapeutic response of body dysmorphic disorder (BDD) in autism spectrum disorder (ASD)
por: Pedrero, A. Alvarez, et al.
Publicado: (2021)

La COVID-19 en los resultados de salud en mujeres con trastorno mental grave
por: González-Rodríguez, Alexandre, et al.
Publicado: (2022)

COVID-19 and physical health of women with severe mental illness()
por: González-Rodríguez, Alexandre, et al.
Publicado: (2022)

Feasibility of Intranasal Dexmedetomidine in Treatment of Postoperative Restlessness, Agitation, and Pain in Geriatric Orthopedic Patients
por: Uusalo, Panu, et al.
Publicado: (2021)

Effect of Intramuscular Ketamine versus Haloperidol on Short-Term Control of Severe Agitated Patients in Emergency Department; A Randomized Clinical Trial
por: Heydari, Farhad, et al.
Publicado: (2018)

ACUTE SCHIZOPHRENIC EPISODES—ARE THEY SCHIZOPHRENIC?
por: Singh, Gurmeet, et al.
Publicado: (1981)

Emergence agitation prevention in paediatric ambulatory surgery: A comparison between intranasal Dexmedetomidine and Clonidine
por: Mukherjee, Anindya, et al.
Publicado: (2015)

Effect of intranasal dexmedetomidine on emergence agitation after sevoflurane anesthesia in children undergoing tonsillectomy and/or adenoidectomy
por: El-Hamid, Ahmed Mostafa Abd, et al.
Publicado: (2017)

Intranasal cerium oxide nanoparticles improves locomotor activity and reduces oxidative stress and neuroinflammation in haloperidol-induced parkinsonism in rats
por: Mohammad, et al.
Publicado: (2023)

F82. COGNITIVE BIASES IN PATIENTS WITH SCHIZOPHRENIA AND HIGH SCHOOL STUDENTS: ASSOCIATION WITH PSYCHOPATHOLOGICAL SYMPTOMS
por: Estrada, Francesc, et al.
Publicado: (2018)

F87. SERUM PROLACTIN LEVELS AND COGNITIVE OUTCOME IN FIRST EPISODE PSYCHOSIS: A PROSPECTIVE 1-YEAR FOLLOW-UP STUDY
por: Bonet, Meritxell Tost, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2u6m4i1jj1c0upukg28suadgci